Novavax Inc (WBO:NVAX)
€ 9.276 -0.09 (-0.96%) Market Cap: 1.49 Bil Enterprise Value: 734.28 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 47/100

Novavax Inc at Bank of America Global Healthcare Conference Transcript

May 11, 2023 / 05:00PM GMT
Alec Warren Stranahan
BofA Securities, Research Division - Associate

Hello Everyone, good afternoon, and welcome to -- or I guess, good morning. Welcome to day 3 of the 2023 BofA Healthcare Conference. Thanks for joining the session with Novavax. My name is Alec Stranahan. I'm Vice President and senior biotech analyst covering Novavax at BofA. And I'm pleased to be joined by John Jacobs, President and Chief Executive Officer of Novavax, as well as Filip Dubovsky, Executive Vice President and Chief Medical Officer.

Thanks for being here, guys.

John Charles Jacobs
Novavax, Inc. - President, CEO & Director

Our pleasure. And thanks to those of you who joined us live as well. This is one of the last sessions of the conference. I appreciate you being here.

Alec Warren Stranahan
BofA Securities, Research Division - Associate

Saving the best for last.

Questions & Answers

Alec Warren Stranahan
BofA Securities, Research Division - Associate

Yes. So let

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot